Catalyst
Slingshot members are tracking this event:
CymaBay's(CBAY) Seladelpar in Primary biliary cholangitis (PBC) Data from completed Phase 2 trial to be presented at DDW May 20, 2019
- Source Link:
- https://ir.cymabay.com/press-releases/detail/459
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| CBAY | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
May 20, 2019
Occurred Source:
https://ir.cymabay.com/press-releases/detail/460/cymabay-therapeutics-presents-data-in-patients-with-primary-biliary-cholangitis-at-ddw-2019
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Seladelpar, Primary Biliary Cholangitis, Phase 2 Clinical Trial Data
